VUMC News and Communications

February 17, 2012

Employee Celebration free screening of ‘How to Train Your Dragon’ Feb. 26

By VUMC News and Communications
February 15, 2012

Portion of 21st Avenue South to be closed this weekend; other closure

By VUMC News and Communications
February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

By VUMC News and Communications
February 13, 2012

Flexner Lecture to discuss medical school curriculum reform

By VUMC News and Communications
February 13, 2012

Take advantage of these opportunities to support Children’s Hospital

By VUMC News and Communications
February 10, 2012

Opinion: Scientific research is essential to state’s economic health

In this Tennessean opinion piece, Vice Chancellor for Health Affairs Jeff Balser discusses the impact scientific research has in Tennessee and the critical importance of continued federal investment in this research.

By VUMC News and Communications
February 10, 2012

Dr. Howard Kirshner on stroke prevention

By VUMC News and Communications
February 3, 2012

Help put childhood cancer on ice at Predators game March 10

By VUMC News and Communications
February 2, 2012

Dr. Michael Neuss: “How much progress has been made in the fight against cancer?”

By VUMC News and Communications
February 1, 2012

Treatment window for genetic disorder

Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.
By VUMC News and Communications
February 1, 2012

Drugs reverse lung cancer cell changes

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
By VUMC News and Communications
January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
By VUMC News and Communications
1 … 379 380 381 382 383 … 436